{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:55:59Z","timestamp":1781520959026,"version":"3.54.1"},"reference-count":13,"publisher":"National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)","issue":"1","license":[{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. oncol."],"abstract":"<jats:p>Primary leiomyomas of the vascular system, particularly of the inferior vena cava (IVC), are extremely rare benign vascular tumors, which, due to their extraluminal growth, can mimic tumors of the adjacent organs. The report pre- sents the case of IVC leiomyoma in a patient with a complicated hematological history, with recently treated idiopathic thrombocytopenia, to demonstrate the complexity of the differential diagnosis of retroperitoneal neoplasms. The case clearly demonstrates the limitations in diagnosing IVC tumors, even using modern imaging techniques, in cases of their extraluminal growth. Only the use of an aggressive surgical approach (en bloc resection of the tumor with the involved vascular wall) in combination with morphological and immunohistochemical verification guarantees an accurate diag- nosis and favorable prognosis.<\/jats:p>","DOI":"10.15407\/exp-oncology.2026.01.073","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:30:56Z","timestamp":1781519456000},"page":"73-76","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Case of Inferior Vena Cava Leiomyoma in a Patient with Thrombocytopenia"],"prefix":"10.15407","volume":"48","author":[{"given":"Y.","family":"Dumanskiy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Reshetniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ievtushenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bondar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mykhailyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"32237","published-online":{"date-parts":[[2026,6,14]]},"reference":[{"key":"17389","doi-asserted-by":"crossref","unstructured":"Zhou X, Qi X, Zhao X, et al. Update on clinical characteristics and molecular insights for uterine intravenous leiomyomatosis (Review). Oncol Lett. 2023;27(1):31. https:\/\/doi.org\/10.3892\/ol.2023.14165","DOI":"10.3892\/ol.2023.14165"},{"key":"17390","doi-asserted-by":"crossref","unstructured":"Wang Q, Liu H, Feng W. Unraveling the challenges of intravenous leiomyomatosis: A retrospective analysis of 11 cases. Arch Gynecol Obstet. 2024;309(2):621-629. https:\/\/doi.org\/10.1007\/s00404-023-07308-x","DOI":"10.1007\/s00404-023-07308-x"},{"key":"17391","doi-asserted-by":"crossref","unstructured":"Volfson E, Moshkovich M, Koen J, et al. Management of intravenous leiomyomatosis: a comprehensive review of surgical and perioperative considerations. Int J Gynecol Cancer. 2025;35(10):102009. https:\/\/doi.org\/10.1016\/j.ijgc.2025.102009","DOI":"10.1016\/j.ijgc.2025.102009"},{"key":"17392","doi-asserted-by":"crossref","unstructured":"Wen Y, Ma G, Miao Q, et al. The largest single-center report on intravenous leiomyomatosis and development of a classification to guide surgical management. J Vasc Surg Venous Lymphat Disord. 2025;13(1):101989. https:\/\/doi.org\/10.1016\/j.jvsv.2024.101989","DOI":"10.1016\/j.jvsv.2024.101989"},{"key":"17393","doi-asserted-by":"crossref","unstructured":"Wang J, Hu Q, Bi Z, et al. MR imaging findings of stage I intravenous leiomyomatosis: a retrospective single-center study in 19 cases. Abdom Radiol (NY). 2024;49(2):512-522. https:\/\/doi.org\/10.1007\/s00261-023-04132-4","DOI":"10.1007\/s00261-023-04132-4"},{"key":"17394","doi-asserted-by":"crossref","unstructured":"Dong Y, Huang S, Wu H, et al. A rare case of intravenous leiomyomatosis extending along the right ovarian vein, right internal iliac, and inferior vena cava to the right atrium observed by [18F]FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2024;51:1197\u20131198. https:\/\/doi.org\/10.1007\/s00259-023-06509-5","DOI":"10.1007\/s00259-023-06509-5"},{"key":"17395","doi-asserted-by":"crossref","unstructured":"Gong Q, Xue N. Imaging findings of a case report of intravenous lipoleiomyomatosis. AME Case Rep. 2024;8:77. https:\/\/doi.org\/10.21037\/acr-24-21","DOI":"10.21037\/acr-24-21"},{"key":"17396","unstructured":"Cabral JM, Mendes D, Pereira C, et al. What is hidden behind persistent Inferior vena cava thrombosis? Angiol Cir Vasc. 2025;21(1):38-40. https:\/\/doi.org\/10.48750\/acv.619"},{"key":"17397","doi-asserted-by":"crossref","unstructured":"Rodrigues MM, Po\u00e7as PD, Portugal RV, et al. Uterine leiomyoma with intravascular leiomyomatosis. Radiographics. 2024;44(12):e240204. https:\/\/doi.org\/10.1148\/rg.240204","DOI":"10.1148\/rg.240204"},{"key":"17398","doi-asserted-by":"crossref","unstructured":"Zhang G, Yu X, Lang J, et al. Analysis of risk factors for post-operative recurrence or progression of intravenous leiomyomatosis. Int J Gynecol Cancer. 2024;34(5):705-712. https:\/\/doi.org\/10.1136\/ijgc-2023-005108","DOI":"10.1136\/ijgc-2023-005108"},{"key":"17399","doi-asserted-by":"crossref","unstructured":"Moshkovich M, Volfson E, Cusimano RJ, et al. Management of intravenous leiomyomatosis: a case report illustrating two distinct surgical approaches. Gynecol Oncol Rep. 2025;59:101762. https:\/\/doi.org\/10.1016\/j.gore.2025.101762","DOI":"10.1016\/j.gore.2025.101762"},{"key":"17400","doi-asserted-by":"crossref","unstructured":"Shi Y, Wang J, Jiang X, et al. The treatment of intravascular leiomyomatosis with different clinical manifestations: two case reports. Medicine (Baltimore). 2025;104(36):e44406. https:\/\/doi.org\/10.1097\/MD.0000000000044406","DOI":"10.1097\/MD.0000000000044406"},{"key":"17401","doi-asserted-by":"crossref","unstructured":"Teixeira B, Neves MC, Fonseca F, et al. Intravenous leiomyomatosis: A case report and narrative literature review. Int J Gynaecol Obstet. 2025;171(1):170-176. https:\/\/doi.org\/10.1002\/ijgo.70195","DOI":"10.1002\/ijgo.70195"}],"container-title":["Experimental Oncology"],"original-title":[],"link":[{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/download\/621\/466","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/download\/621\/466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:40:12Z","timestamp":1781520012000},"score":1,"resource":{"primary":{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/view\/621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,14]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,14]]}},"URL":"https:\/\/doi.org\/10.15407\/exp-oncology.2026.01.073","relation":{},"ISSN":["2312-8852","1812-9269"],"issn-type":[{"value":"2312-8852","type":"electronic"},{"value":"1812-9269","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,14]]}}}